Clinical care and research, delivered by the same team.

A physician reviews a tablet with a patient in a clinic hallway.

Our Advantage

National scale. Neurology depth. Local patient relationships.

30,000+

Neurology patients

19

Neurologists

7

Research sites

150+

Trials

Therapeutic Areas

Focused on the full spectrum of neurological conditions.

Deep expertise and established patient populations across our core therapeutic areas.

MS & neuroimmunology

Multiple sclerosis and other immune-mediated disorders of the central nervous system.

6,000+

patients

Movement disorders

Parkinson's disease, essential tremor, dystonia, and other movement disorders.

3,000+

patients

Alzheimer’s & cognitive disorders

Alzheimer's disease, dementia, mild cognitive impairment, and related conditions.

1,500+

patients

Migraine & headache

Chronic migraine, episodic migraine, and other complex headache disorders.

6,000+

patients

Neuromuscular disease

Myasthenia gravis, CIDP, peripheral neuropathies, and other neuromuscular conditions.

5,750+

patients

Our Research Sites

Where research meets community care.

Why Nira Clinical Research

A streamlined, integrated approach to clinical trials.

Experienced in-house research team

Coordinators and PIs in our clinics.

Single point of contact

One team for BD and study feasibility.

Patients already in our care

Identified through one central EHR.

One budget and contract

Negotiated once, for all sites.

Centralized study startup

One POC from award to go-live.

Quality and training support

Standardized QA and operating processes.

In-house infusion services

On-site IP administration and oversight.

One Organization, One Team

Research delivered by the same team in our community neurology practices.

Elizabeth L. Peckham, DO

Neurology has always been a fascinating and rewarding field, but what excites me most is the opportunity to be part of a clinical research team advancing the future of medicine. Through clinical trials, we give our patients the opportunity to contribute to the development of tomorrow’s treatments and play an important role in shaping the future of neurological care. Ultimately, our goal is to advance therapies that may one day slow, stop, or even reverse the progression of these conditions.

April Erwin, MD

Access to clinical trials matters for patients living with MS because it allows us to advance an individual patient’s treatment plan while also advancing the entire field of MS through new innovations. When trials are available under the same roof, patients can keep receiving care from the team they already know and trust, without traveling to a distant site or disrupting their families and routines. The next frontier in MS care involves not just preventing relapses and new MRI lesions, but truly repairing and restoring the damage that’s been done.

Daniel Orme, MD

We are not only treating patients with the best available care, we are also exploring new treatment options all the time. Because our research happens in the same place where patients receive their care, I can bring a relevant trial to a patient’s attention right away and get them set up for a clinical trial consultation if it’s right for them. Our research looks at treatments that go above and beyond what is currently available, and at more individualized approaches that strike the balance between efficacy and safety.

Partner with Nira Clinical Research

Let’s advance what’s next in neurology.

Whether you’re a sponsor, CRO or a patient interested in clinical trials, we’re here to help.

A physician in a white coat reviews a tablet while talking with a patient in a bright clinic waiting area.